Showing results (691-700 of 730) with videos related to

Sort By:
Pageof 73
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
A Pyrimidine-Based Tubulin Inhibitor Shows Potent Anti-Glioblastoma Activity In Vitro and In VivoSatyanarayana Pochampally, Lawrence M Pfeffer, Gustavo A Miranda-Carboni, et al.
Nature Communications|August 6, 2025
Sequencing a DNA analog composed of artificial basesChristopher A Thomas, Henry Brinkerhoff, Jonathan M Craig, et al.
Epidemiology and Infection|December 2, 2005
Nationwide outbreak of listeriosis due to contaminated meatP S Mead, E F Dunne, L Graves, et al.
Ophthalmology. Retina|August 11, 2025
Efficacy of Low-Dose Rate Iodine-125 Plaque Brachytherapy in the Treatment of Uveal MelanomaLinda A Cernichiaro-Espinosa, Sue L Choi, David J Taylor Gonzalez, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 14, 2015
International consensus on use of focused ultrasound for painful bone metastases: Current status and future directionsMerel Huisman, Gail ter Haar, Alessandro Napoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate CancerSuriyan Ponnusamy, Yali He, Dong-Jin Hwang, et al.
Molecular Cancer Research : MCR|May 21, 2024
miR-497 Target Gene Regulatory Network in AngiosarcomaAnnaleigh Benton, Noah M Moriarty, Emma Terwilliger, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 11, 2016
Coassembled nanostructured bioscaffold reduces the expression of proinflammatory cytokines to induce apoptosis in epithelial cancer cellsRui Li, Sivapriya Pavuluri, Kiara Bruggeman, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Target gene regulatory network of miR-497 in angiosarcomaAnnaleigh Benton, Emma Terwilliger, Noah M Moriarty, et al.
Molecular Cancer Therapeutics|December 6, 2008
IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expressionShannon F Rosati, Regan F Williams, Lindsey C Nunnally, et al.
Pageof 73